We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
PROG Holdings
PRG
$1.75B
| $3.03M | ﹤0.01% |
105,571
-149,610
| -59% | -$4.83M |
|
2077
Arbor Realty Trust
ABR
$960M
| $3.03M | ﹤0.01% |
392,492
-5,377
| -1% | -$41.9K |
|
2078
1st Source
SRCE
$2.07B
| $3.03M | ﹤0.01% |
43,713
-67,659
| -61% | -$4.56M |
|
2079
Relay Therapeutics
RLAY
$4.02B
| $3.01M | ﹤0.01% |
302,196
+1,732
| +0.6% | +$15.5K |
|
2080
ING
ING
$93.8B
| $2.99M | ﹤0.01% |
114,889
-4,408
| -4% | -$124K |
|
2081
Universal Corp
UVV
$1.34B
| $2.98M | ﹤0.01% |
56,535
-1,638
| -3% | -$88.2K |
|
2082
Lightbridge
LTBR
$246M
| $2.97M | ﹤0.01% |
278,905
-46,372
| -14% | -$644K |
|
2083
ICF International
ICFI
$1.44B
| $2.97M | ﹤0.01% |
45,522
+4,597
| +11% | +$374K |
|
2084
Triumph Financial Inc
TFIN
$1.84B
| $2.97M | ﹤0.01% |
49,764
+2,373
| +5% | +$148K |
|
2085
Wendy's
WEN
$1.33B
| $2.95M | ﹤0.01% |
424,389
+148,892
| +54% | +$1.15M |
|
2086
Seaboard Corp
SEB
$4.52B
| $2.94M | ﹤0.01% |
520
+50
| +11% | +$251K |
|
2087
United States Antimony
UAMY
$766M
| $2.93M | ﹤0.01% |
335,409
-71,007
| -17% | -$619K |
|
|
VOYG
2088
Voyager Technologies
VOYG
$1.5B
| $2.91M | ﹤0.01% |
124,596
+107,639
| +635% | +$3.09M |
|
2089
Bank First Corp
BFC
$1.67B
| $2.91M | ﹤0.01% |
21,540
+738
| +4% | +$101K |
|
2090
Enterprise Products Partners
EPD
$83.8B
| $2.9M | ﹤0.01% |
76,716
-184,500
| -71% | -$6.53M |
|
2091
Gibraltar Industries
ROCK
$1.34B
| $2.9M | ﹤0.01% |
72,781
+2,087
| +3% | +$101K |
|
2092
German American Bancorp
GABC
$1.82B
| $2.9M | ﹤0.01% |
69,429
+333
| +0.5% | +$13.8K |
|
2093
Keros Therapeutics
KROS
$199M
| $2.89M | ﹤0.01% |
262,075
+198,978
| +315% | +$3.07M |
|
2094
Equity Bancshares
EQBK
$1.03B
| $2.89M | ﹤0.01% |
65,137
+34,591
| +113% | +$1.57M |
|
2095
Nuveen Churchill Direct Lending
NCDL
$599M
| $2.88M | ﹤0.01% |
226,765
+7,357
| +3% | +$98.7K |
|
2096
Solid Biosciences
SLDB
$771M
| $2.88M | ﹤0.01% |
400,292
+5,316
| +1% | +$34.2K |
|
2097
Coursera
COUR
$1.54B
| $2.87M | ﹤0.01% |
493,857
-796,945
| -62% | -$4.98M |
|
2098
Gorman-Rupp
GRC
$2.16B
| $2.87M | ﹤0.01% |
46,252
-553
| -1% | -$32.7K |
|
2099
C3.ai
AI
$1.27B
| $2.87M | ﹤0.01% |
340,852
+1,739
| +0.5% | +$18.7K |
|
2100
Weave Communications
WEAV
$491M
| $2.87M | ﹤0.01% |
620,212
+610
| +0.1% | +$3.55K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.